1-(4-Chlorophenyl)cyclobutanecarbonitrile,
28049-61-8,
1-(4-Chlorophenyl)-1-cyclobutanecarbonitrile,
1-(4-chlorophenyl)cyclobutane-1-carbonitrile,
Cyclobutanecarbonitrile, 1-(4-chlorophenyl),
Cyclobutanecarbonitrile, 1-(4-chlorophenyl)-,
1-(4-Chlorophenyl)-cyclobutanecarbonitrile,
1-(4-Chlorophenyl)cyclobutane Carbonitrile,
EINECS 248-799-7,
NSC154613,
CCBC,
Sibutramine Impurity F,
ACMC-20a2wi,
AC1Q3NKD,
AC1L40AT,
SCHEMBL2218,
(intermediate of Sibutramine),
CYC006,
Jsp005407,
CTK4G0683,
DTXSID30182328,
XQONXPWVIZZJIL-UHFFFAOYSA-N,
ZINC388379,
ANW-54688,
MFCD00065239,
SBB063203,
1-(4-chlorophenyl)cyclobutane nitrile,
AKOS005216180,
CC-1911,
NSC 154613,
NSC-154613,
1--(4-chlorophenyl)cyclobutane nitrile,
1-(p-Chlorophenyl)cyclobutanecarbonitrile,
1-(4-chlorophenyl)cylcobutanecarbonitrile,
AC-19028,
AJ-20588,
AK-37826,
BC214898,
SC-16686,
U337,
ZB011474,
1-(4-Chlorophenyl)cyclobutane-carbonitrile,
1-(4-chloro-phenyl)-cyclobutanecarbonitrile,
DB-011799,
TC-143433,
A5366,
Cyclobutanecarbonitrile,1-(4-chlorophenyl)-,
FT-0082994,
FT-0605678,
FT-0638749,
ST50405608,
1-(4-Chlorophenyl)-1-cyclobutanecarbonitrile, 97%,
I01-0845,
W-107079,
C11H10ClN,
1- -1-cyclobutanecarbonitrile,
C11-H10-Cl-N,
KST-1B2733,
CID98621,
AR-1B1937,
C3161,
28971-03-1,
3-(2-Pyridyl)-5,6-bis(4-sulfophenyl)-1,2,4-triazine Disodium Salt,
Disodium 4,4'-[3-(pyridin-2-yl)-1,2,4-triazine-5,6-diyl]bis(benzenesulphonate),